DiaMedica Therapeutics (DMAC) Share-based Compensation (IS) (2024 - 2026)
DiaMedica Therapeutics' Share-based Compensation (IS) was $1.12 million in Q2 2026, up 45.0% from $771,000 a year earlier and up 36.0% from the prior quarter.
Powered by 
Analysis
DiaMedica Therapeutics (DMAC) Share-based Compensation (IS) (2024 - 2026) Analysis & Trends
On a trailing twelve-month basis, DiaMedica Therapeutics' Share-based Compensation (IS) was $4.15 million through Jun 30, 2026, up 48.6% year-over-year; for FY2025, it came in at $3.85 million, up 84.5% from FY2024.
- In earlier years, Share-based Compensation (IS) was $2.09 million in FY2024 (+23.9%) and $1.68 million in FY2023.
- Quarterly Share-based Compensation (IS) has moved between $443,000 (Q2 2024) and $1.19 million (Q4 2025) over five years.
- Compared with a year earlier, Share-based Compensation (IS) was higher in five of the last six quarters, with growth averaging 62.3%.
- Per Business Quant data, DMAC's Share-based Compensation (IS) in the three quarters before Q2 2026 was $822,000 (Q1 2026), $1.19 million (Q4 2025) and $1.02 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | - |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | - |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | - |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | - |
| 10 | DiaMedica Therapeutics | 442.19 Mn | 442.19 Mn | - | 1.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.12 Mn |
| Mar 31, 2026 | 822,000.00 |
| Dec 31, 2025 | 1.19 Mn |
| Sep 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 771,000.00 |
| Mar 31, 2025 | 867,000.00 |
| Dec 31, 2024 | 589,000.00 |
| Sep 30, 2024 | 565,000.00 |
| Jun 30, 2024 | 443,000.00 |
| Mar 31, 2024 | 488,000.00 |
API Access
DiaMedica Therapeutics Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=DMAC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "DMAC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=DMAC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();